Literature DB >> 2960611

Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.

C A Ottaway1.   

Abstract

Murine lymphocytes have been shown previously to possess high-affinity specific receptors for the neuropeptide vasoactive intestinal peptide (VIP). This study examines the cellular basis for modulation of concanavalin A (Con A)-induced T-cell responses by this neuropeptide. VIP was most effective as an inhibitor when added at the initiation of the mitogen response. The loss of potency when VIP was added later in the response was accompanied by a decrease in the affinity of stimulated cells for the neuropeptide. The inhibitory influence of VIP was reversible if the neuropeptide was removed from stimulated cell cultures up to 6 hr after the initiation of stimulation. In contrast, VIP-mediated inhibition was fully developed once the stimulated cells had been exposed to the neuropeptide for 24 hr. The presence of VIP led to a decreased production of interleukin-2 (IL-2) by the stimulated lymphocytes, but did not affect the expression of Con A-induced suppressor cell activity by cultured lymphocytes. Studies of the effect of selective, complement-mediated killing of cells with Thy 1, L3T4 and Lyt 2 monoclonal antibodies showed that the majority of the VIP bound by the lymphocytes was accounted for by binding to L3T4+, Lyt 2- T cells. It was concluded that VIP exerts its influence over Con A-stimulated proliferation by selective regulation of T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960611      PMCID: PMC1453988     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Biological expressions of lymphocyte activation. IV. Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions.

Authors:  R R Rich; S S Rich
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  The significance of T-B collaboration across haplotype barriers.

Authors:  S L Swain; P E Trefts; H Y Tse; R W Dutton
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

3.  Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function.

Authors:  S L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

4.  On the immunocytochemical localization of the vasoactive intestinal polypeptide.

Authors:  L I Larsson; J M Polak; R Buffa; F Sundler; E Solcia
Journal:  J Histochem Cytochem       Date:  1979-05       Impact factor: 2.479

5.  Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase.

Authors:  M S O'Dorisio; N S Hermina; T M O'Dorisio; S P Balcerzak
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

Review 6.  Interleukin 2: biology and biochemistry.

Authors:  S Gillis
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

7.  Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

Authors:  A M Stanisz; D Befus; J Bienenstock
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  Interaction of vasoactive intestinal peptide with human blood mononuclear cells.

Authors:  J M Guerrero; J C Prieto; F L Elorza; R Ramirez; R Goberna
Journal:  Mol Cell Endocrinol       Date:  1981-02       Impact factor: 4.102

9.  Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

10.  T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.

Authors:  J A Ledbetter; R V Rouse; H S Micklem; L A Herzenberg
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  17 in total

1.  Modulatory effect of rat small intestinal epithelial cell-conditioned medium on lymphocyte proliferation.

Authors:  K Tanaka; N Yabe; H Matsui
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-01       Impact factor: 2.416

2.  Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.

Authors:  C Ishioka; A Yoshida; H Kimata; H Mikawa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

3.  Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.

Authors:  Sheri Tinnell Dorsam; Emilie Vomhof-Dekrey; Rebecca J Hermann; Jodie S Haring; Travis Van der Steen; Erich Wilkerson; Goran Boskovic; James Denvir; Yulia Dementieva; Donald Primerano; Glenn Paul Dorsam
Journal:  Mol Immunol       Date:  2010-02-01       Impact factor: 4.407

Review 4.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

6.  In vivo neural isolation of the canine jejunoileum: temporal adaptation of enteric neuropeptides.

Authors:  D K Nelson; M G Sarr; V L Go
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

7.  Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide.

Authors:  A I Roberts; A Panja; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

8.  Induction of aggregation of Raji human B-lymphoblastic cells by vasoactive intestinal peptide.

Authors:  A Robichon; S P Sreedharan; J Yang; R S Shames; E C Gronroos; P P Cheng; E J Goetzl
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.

Authors:  S Fujieda; J A Waschek; K Zhang; A Saxon
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

10.  Neonatal capsaicin pretreatment suppresses intramedullary inflammation in adjuvant-induced spondylitis.

Authors:  S Imai; S Hukuda; T Maeda
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.